| abstract |
The present invention provides a method for screening in vitro or in vivo candidate compounds for the prophylactic or curative treatment of acne, seborrheic dermatitis, or skin disorders associated with sebum hypersecretion, comprising: Any of these enzymes for treating acne, seborrheic dermatitis, or skin disorders associated with hyperlipidemic secretion, comprising a step comprising determining the ability of a compound to modulate the expression or activity of CoA dehydrogenase It also relates to the use of modulators for such expression or activity. The present invention also relates to a method for diagnosing or prognosing these lesions in vitro. |